Emiko Ohki
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Correction to: Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor.
Journal: Investigational new drugs
Published: March 24, 2019
Treatment status and safety of crizotinib in 2028 Japanese patients with ALK-positive NSCLC in clinical settings.
Journal: Japanese journal of clinical oncology
Published: February 12, 2019
Real-world use of sunitinib in Japanese patients with pancreatic neuroendocrine tumors: results from a post-marketing surveillance study.
Journal: Cancer chemotherapy and pharmacology
Published: September 30, 2018
Interstitial Lung Disease Onset and Its Risk Factors in Japanese Patients With ALK-Positive NSCLC After Treatment With Crizotinib.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 31, 2018
Efficacy and safety of sunitinib in Japanese patients with progressive, advanced/metastatic, well-differentiated, unresectable pancreatic neuroendocrine tumors: final analyses from a Phase II study.
Journal: Japanese journal of clinical oncology
Published: August 15, 2018
Crizotinib versus Chemotherapy in Asian Patients with ALK-Positive Advanced Non-small Cell Lung Cancer.
Journal: Cancer research and treatment
Published: June 10, 2017
Safety, efficacy and prognostic analyses of sunitinib in the post-marketing surveillance study of Japanese patients with gastrointestinal stromal tumor.
Journal: Japanese journal of clinical oncology
Published: June 05, 2015
Fungal peritonitis associated with Curvularia geniculata and Pithomyces species in a patient with vulvar cancer who was successfully treated with oral voriconazole.
Journal: The Journal of antibiotics
Published: January 24, 2013
Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor.
Journal: Investigational new drugs
Published: September 04, 2012
Relationship between the clinical efficacy and AUC/MIC of intravenous ciprofloxacin in Japanese patients with intraabdominal infections.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: December 15, 2011
Phase I and pharmacokinetic study of dacomitinib (PF-00299804), an oral irreversible, small molecule inhibitor of human epidermal growth factor receptor-1, -2, and -4 tyrosine kinases, in Japanese patients with advanced solid tumors.
Journal: Investigational new drugs
Published: November 30, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026